Research and Markets: Pancreatic Cancer Pipeline Report 2014
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/n5grdd/pancreatic_cancer) has announced the addition of the "Pancreatic Cancer Pipeline Highlights - 2014 Update" report to their offering.
“Pancreatic Cancer Pipeline Highlights - 2014 Update”
The latest report Pancreatic Cancer Pipeline Highlights - 2014 Update, provides most up-to-date information on key pipeline molecules in the global Pancreatic Cancer market. It covers emerging therapies for Pancreatic Cancer in active clinical development stages including early and late stage clinical trials.
The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
Key Topics Covered:
1. Pancreatic Cancer Pipeline by Stages
2. Pancreatic Cancer Pipeline by Drug Class
3. Pancreatic Cancer Pipeline by Company
4. Pancreatic Cancer Phase 3 Clinical Trial Insights
5. Pancreatic Cancer Phase 2 Clinical Trial Insights
6. Pancreatic Cancer Phase 1 Clinical Trial Insights
7. Pancreatic Cancer Preclinical Research Insights
8. Pancreatic Cancer Discovery Stage Insights
For more information visit http://www.researchandmarkets.com/research/n5grdd/pancreatic_cancer